The role of mTOR pathway as target for treatment in adrenocortical cancer
Adrenocortical carcinomas (ACCs) are rare tumors with scant treatment options for which new treatments are required. The mTOR pathway mediates the intracellular signals of several growth factors, including the insulin-like growth factors (IGFs), and therefore represents a potential attractive pathwa...
Main Authors: | Maria Cristina De Martino, Richard A Feelders, Claudia Pivonello, Chiara Simeoli, Fortuna Papa, Annamaria Colao, Rosario Pivonello, Leo J Hofland |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2019-09-01
|
Series: | Endocrine Connections |
Subjects: | |
Online Access: | https://ec.bioscientifica.com/view/journals/ec/8/9/EC-19-0224.xml |
Similar Items
-
Clinical decision making in small non-functioning VHL-related incidentalomas
by: Roland Därr, et al.
Published: (2020-09-01) -
Thyroid-disrupting chemicals and brain development: an update
by: Bilal B Mughal, et al.
Published: (2018-04-01) -
Tumour diameter is not reliable for management of non-secreting pancreatic neuroendocrine tumours
by: Logan Mills, et al.
Published: (2017-11-01) -
Molecular mechanisms of endocrine disruption in the hypothalamus throughout the life cycle
by: Walker, Deena Marie
Published: (2013) -
How to Differentiate Benign from Malignant Adrenocortical Tumors?
by: Charlotte L. Viëtor, et al.
Published: (2021-08-01)